Cosmo Pharmaceuticals NV
LSE:0RGI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cosmo Pharmaceuticals NV
LSE:0RGI
|
IE |
|
S
|
Swedish Match AB
F:SWM0
|
SE |
|
R
|
Rocket Companies Inc
XBER:RC5
|
US |
|
C
|
CITIC Ltd
SWB:CPF
|
CN |
|
S
|
Swire Pacific Ltd
XMUN:SWI
|
HK |
|
Heineken NV
LSE:0O26
|
NL |
|
G
|
General Motors Co
XHAM:8GM
|
US |
|
M
|
MGM Resorts International
F:MGG
|
US |
Dividends
Dividend Yield
Cosmo Pharmaceuticals NV
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Cosmo Pharmaceuticals NV
0RGI have decreased by 0%.
Payout Ratio
Cosmo Pharmaceuticals NV
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 0RGI is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
0RGI Price
Cosmo Pharmaceuticals NV
| Average Annual Return | -6.09% |
| Standard Deviation of Annual Returns | 20.9% |
| Max Drawdown | -83% |
| Market Capitalization | 1.2B CHF |
| Shares Outstanding | 15 002 100 |
| Percentage of Shares Shorted |
N/A
|
